A comprehensive analysis of the significance of immunogenic cell death-related genes in the prognosis and immune microenvironment of patients with bladder cancer
Abstract:Background
BLCA is the second most common urogenital malignancy. In recent years, although the use of neoadjuvant and adjuvant chemotherapy has been thoroughly studied, the prognosis of metastatic BLCA is still poor. In order to improve the survival of BLCA patients and the accuracy of their response to individualized therapy, we need to further explore more novel BLCA biomarkers.Immunogenic cell death (ICD), a unique form of regulatory cell death, not only plays an important role in the immune process, but a… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.